Lotiglipron
A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Pfizer · Phase 1 · Terminated · Enrollment 16
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Period 1 | n/r | n/r | n/r | n/r | n/r |
| Period 2 | n/r | n/r | n/r | n/r | n/r |
| Period 3 | n/r | n/r | n/r | n/r | n/r |
| Period 4 | n/r | n/r | n/r | n/r | n/r |
| Period 5 | n/r | n/r | n/r | n/r | n/r |
| Period 6 | n/r | n/r | n/r | n/r | n/r |
| Period 7 | n/r | n/r | n/r | n/r | n/r |
| Period 8 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.